Nut Hypersensitivity clinical trials

The registry lists 33 studies for Nut Hypersensitivity across more than 10 countries. 9 are recruiting or about to start. 16 of them are mainly about Nut Hypersensitivity (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20.

Get an email when these change. Save the Nut Hypersensitivity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 15
Recruiting: 6
Not yet recruiting: 3
Status unknown: 3
Active, not recruiting: 2
Terminated: 2

Phase

Phase 1: 6
Phase 2: 6
Phase 3: 1

Where

United States: 8
Australia: 4
Canada: 3
Finland: 3
Poland: 2
United Kingdom: 2

Who runs them

Hamilton Health Sciences Corporation (2) · University of North Carolina, Chapel Hill (2) · Lille Catholic University (2) · Murdoch Childrens Research Institute (2) · Alladapt Immunotherapeutics, Inc. (2) · King's College London (2) · Helsinki University Central Hospital (2) · Medical University of Warsaw (2)

What is being tested here

Drugs under test in Nut Hypersensitivity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Acalabrutinib	0	0	1
cow's milk	0	0	1
Trichuris suis EGG	0	0	1
Cizutamig	0	0	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Nov 2026TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation · Hamilton Health Sciences Corporation
Dec 2026Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets · Luxembourg Institute of Health

Who these studies take

Of the 6 Nut Hypersensitivity studies recruiting now, 0 (0%) set no upper age limit and 6 (100%) stop at 75 or younger. 6 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (67%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	6 (100%)	6 (100%)
18	2 (33%)	2 (33%)
30	2 (33%)	2 (33%)
40	2 (33%)	2 (33%)
50	2 (33%)	2 (33%)
65	2 (33%)	2 (33%)
75	1 (17%)	1 (17%)
85	0 (0%)	0 (0%)

Across all 33 studies, recruiting or not: 91% stop at 75 or younger and 85% at 65; 85% take children; 0% are for women only and 0% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 33 of 33. search them.